Jacob Bartlett
Corpus Christi, TXNPI 1487325569
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (43.3%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Legend Biotech USA Inc. accounts for 62.5% of it on its own, with 24 other manufacturers making up the rest. 2025 is the largest year on record at $3,328, more than ten times the $225 reported in 2023.
Across 65 payments — averaging $99.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Legend Biotech USA Inc.$4K
- Johnson & Johnson$283
- Incyte Corporation$272
- Jazz Pharmaceuticals Inc.$225
- Bristol Myers Squibb$217
- Janssen Scientific Affairs, LLC$195
- plus $1K from 19 others
What the payments were for
- Consulting fees$2,49839%
- Travel & lodging$1,17018%
- Food & beverage$2,80343%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Legend Biotech USA Inc. | 19 | $4,047 |
| Johnson & Johnson | 4 | $283 |
| Incyte Corporation | 3 | $272 |
| Jazz Pharmaceuticals Inc. | 2 | $225 |
| Bristol Myers Squibb | 6 | $217 |
| Janssen Scientific Affairs, LLC | 4 | $195 |
| Secura Bio, Inc. | 2 | $170 |
| Genmab U.S., Inc. | 2 | $157 |
| Astellas Pharma US Inc | 2 | $146 |
| Gilead | 2 | $143 |
| Servier Pharmaceuticals LLC | 1 | $125 |
| Rigel Pharmaceuticals, Inc. | 1 | $115 |
| Genentech USA, Inc. | 4 | $92 |
| Syndax Pharmaceuticals, Inc. | 2 | $43 |
| AbbVie | 1 | $28 |
| Beone Medicines USA, Inc. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Merck | 1 | $24 |
| AstraZeneca | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $20 |
| La Jolla Pharmaceutical Company | 1 | $19 |
| Novartis | 1 | $18 |
| Amgen | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.